Propofol Shortage Due to Covid-19

by | Tuesday, March 16, 2021 | 0 comment(s)

Propofol Shortage Due to Covid-19

The unanticipated increased use of Propofol as a sedative for ventilated patients has strained the nation’s Propofol supply for intensive care units. As a result, the FDA has issued an Emergency Use Authorization (EUA) for emergency use of the Propoven 2% Emulsion to maintain sedation via continuous infusion in patients 16 years and older who require mechanical ventilation in an intensive care unit (ICU) during the COVID-19 pandemic.

What is the difference in 1% and 2% 
1% = 10 mg per mL 
2% = 20 mg per mL

The 2% Emulsion contains the same active ingredient, Propofol but in a higher concentration. Propofol 2% has double the concentration of Propofol. 

*Please see the Institute for Safe Medication Practices (ISMP) Special Edition Newsletter for further details.
This entry was posted in no categories.

You must be logged in to post comments.